| Molecular formula | C28H35N5O4 |
| Molecular weight | 505.6 g/mol |
| Registered trials | 0 |
| PubChem CID | 216208 |
Anyone researching capromorelin usually wants to know what the compound actually is and how much clinical evidence exists behind it. This overview summarizes what is publicly documented, without going beyond the available data.
What capromorelin is
Capromorelin is a small molecule with the chemical formula C28H35N5O4 and a molecular weight of about 505.6. It is catalogued under PubChem CID 216208. No FDA label details, mechanism description, or pharmacologic class information were available in the data reviewed for this monograph, so no claims about how it acts in the body are made here.
Trial footprint
The clinical trial registry data reviewed for capromorelin shows a count of zero registered trials, and no sample trial records were available to summarize. This means no phase, status, or study detail can be reported at this time based on the data provided.
Reported side effects
No adverse event report data was available for capromorelin in the data reviewed, so no side effect summary can be provided here.
FAQ
Capromorelin is a small-molecule compound identified in chemical databases under PubChem CID 216208, with a molecular formula of C28H35N5O4. Detailed label, mechanism, and indication information were not available in the data reviewed for this monograph.
This monograph draws on data marked as approved status, but no specific label indications, brand names, or approved uses were available in the dataset reviewed. Readers should consult official regulatory sources for definitive approval details.
The data reviewed lists zero registered clinical trials for capromorelin, and no sample trial records were provided. This limits what can be said about the current clinical evidence base.
No adverse event report data was available in the dataset reviewed for capromorelin, so no side effect pattern can be summarized at this time.
Capromorelin has the molecular formula C28H35N5O4 and a molecular weight of approximately 505.6. It is catalogued in PubChem under CID 216208.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem DailyMed ClinicalTrials.gov registry data
Updated 2026-09-26